Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03627897Phase 4Completed
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Cukurova University. Primary endpoint: Total Morphine Consumption at 24 hours. Started Aug 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03627897.